US BioTec Inc
US BioTec, Inc. engages in the development, manufacture, marketing, and distribution of bio-degradable, nontoxic, and noncarcinogenic products in the United States. Its product portfolio consists of approximately 30 products, which stimulate plants that produce crops; correct microbial and mineral problems present in soils; and rehabilitate the soil ecosystem by breaking down the residual build-u… Read more
US BioTec Inc (USBC) - Total Liabilities
Latest total liabilities as of March 2005: $588.16K USD
Based on the latest financial reports, US BioTec Inc (USBC) has total liabilities worth $588.16K USD as of March 2005.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
US BioTec Inc - Total Liabilities Trend (2003–2005)
This chart illustrates how US BioTec Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
US BioTec Inc Competitors by Total Liabilities
The table below lists competitors of US BioTec Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Critical Solutions
PINK:CSLI
|
USA | $620.33K |
|
Consolidated Eco-Systems Inc
PINK:EXSO
|
USA | $21.88 Million |
|
Ormet Corporation
PINK:ORMTQ
|
USA | $384.77 Million |
|
Compliance Energy Corporation
OTCGREY:CPYCF
|
USA | $1.06 Million |
|
China BCT Pharmacy Group Inc
PINK:CNBI
|
USA | $114.83 Million |
|
Piksel Inc
PINK:PIKL
|
USA | $146.85 Million |
|
New Frontier Energy Inc
PINK:NFEI
|
USA | $108.08K |
|
Rainforest Resources Inc
OTCQB:RRIF
|
USA | $8.73 Million |
Liability Composition Analysis (2003–2005)
This chart breaks down US BioTec Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.46 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.67 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.63 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how US BioTec Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for US BioTec Inc (2003–2005)
The table below shows the annual total liabilities of US BioTec Inc from 2003 to 2005.
| Year | Total Liabilities | Change |
|---|---|---|
| 2005-12-31 | $720.90K | +11.89% |
| 2004-12-31 | $644.28K | -6.01% |
| 2003-12-31 | $685.50K | -- |